Crypto News

Apr 27, 2026

Eli Lilly (LLY) Stock: Pharmaceutical Giant Acquires Ajax Therapeutics in $2.3B Blood Cancer Deal

Stocks

Eli Lilly (LLY) acquires Ajax Therapeutics for $2.3B, adding AJ1-11095, a novel JAK2 inhibitor for myelofibrosis and blood cancers to its pipeline.

The post Eli Lilly (LLY) Stock: Pharmaceutical Giant Acquires Ajax Therapeutics in $2.3B Blood Cancer Deal appeared first on Blockonomi.

Source: Blockonomi →

Related News

Trending Category

$BHYP$RKC$USOR13F Filing1INCH1inch200-Week MA200-day moving average21Shares21Shares HYPE ETF21shares Hyperliquid21shares Hyperliquid ETF26 EMA3-Day Candlestick3iQ50 week MA@CryptoCupra@Sherlockwhales@Whiplash437A7A5

Latest News